Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer. Felip E, Metro G, Tan DSW, Wolf J, et al. Lung Cancer 2024;192:107820.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Felip E, Metro G, Tan DSW, Wolf J, et al. Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer. Lung Cancer 2024;192:107820.
PMID: 38763104